# Xeriant, Inc.: Form 10-Q for the period ended Dec 31, 2017

- Company: [Xeriant, Inc.](/companies/xeri.md) (CIK 1481504)
- Form: 10-Q
- Filed: 2019-06-26
- Accepted by EDGAR: Jun 26, 2019, 06:05 ET
- Period: 2017-12-31
- Accession: 0001477932-19-003699
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1481504/000147793219003699/banj_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1481504/000147793219003699/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 6 months, 2017-07-01 to 2017-12-31 | $79.8k | us-gaap:Revenues |
| Gross profit | 6 months, 2017-07-01 to 2017-12-31 | $60.1k | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2017-10-01 to 2017-12-31 | $0 | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2017-07-01 to 2017-12-31 | $7.0k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2017-10-01 to 2017-12-31 | −$126.9k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2017-07-01 to 2017-12-31 | −$258.5k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2017-10-01 to 2017-12-31 | $87.5k | us-gaap:InterestExpense |
| Interest expense | 6 months, 2017-07-01 to 2017-12-31 | $174.2k | us-gaap:InterestExpense |
| Net income | 3 months, 2017-10-01 to 2017-12-31 | −$227.8k | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2017-07-01 to 2017-12-31 | −$459.5k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2017-10-01 to 2017-12-31 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2017-07-01 to 2017-12-31 | −$0.01 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2017-10-01 to 2017-12-31 | $0.00 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2017-07-01 to 2017-12-31 | −$0.01 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2017-10-01 to 2017-12-31 | 69,584,149 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2017-07-01 to 2017-12-31 | 69,584,149 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2017-07-01 to 2017-12-31 | −$907 | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Current assets | at 2017-12-31 | $501 | us-gaap:AssetsCurrent |
| Total assets | at 2017-12-31 | $6.9k | us-gaap:Assets |
| Current liabilities | at 2017-12-31 | $3.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2017-12-31 | $3.7m | us-gaap:Liabilities |
| Shareholders' equity | at 2017-12-31 | −$3.7m | us-gaap:StockholdersEquity |

## Risk factors

As filed, 157 characters.

Our business is subject to numerous risks and uncertainties including but not limited to those discussed in “Risk Factors” in our Annual Report on Form 10-K.

Filed Jun 26, 2019.
Source: SEC EDGAR, the filing index for accession 0001477932-19-003699. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.